期刊文献+

两种不同方法治疗不稳定型心绞痛的疗效观察 被引量:12

Observing the Effect of Two Ways in Treating Patients with Unstable Angina Pectoris
下载PDF
导出
摘要 目的:探讨两种不同的方法治疗不稳定型心绞痛(UAP)的临床效果。方法:将2008年1月至2010年1月间在我院住院治疗的不稳定型心绞痛患者68例随机分为观察组和对照组,对照组给予低分子肝素钙注射液及辛伐他汀治疗,观察组给予氯吡格雷片及瑞舒伐他汀治疗。结果:治疗后观察组患者在TC、LDL-C及HDL-C改善方面明显优于对照组,两组比较差异具有统计学意义(P>0.05)。观察组总有效率为97.06%,对照组为82.35%,两组比较差异具有统计学意义(P>0.05);观察组心血管事件发生率为2.94%,对照组为17.65%,两组比较差异具有统计学意义(P>0.05);两组患者均未见明显的药物不良反应。结论:氯吡格雷片及瑞舒伐他汀治疗不稳定型心绞痛的临床效果更好,值得应用。 Objective:To investigate the effect of two ways in treating cases with unstable angina pectoris.Method:The 68 cases with unstable angina pectoris in our hospital from January in 2008 to January in 2010 were divided into the observing group and the control group,the observing group received the treatment of nadroparin calcium injection combined with simvastatin and the control group received the treatment of clopidogrel combined with rosuvastatin.Result:The TC,LDL-C and HDL-CFEV1 in the observing group was superior to that in control group,and there was significant difference in them respectively(P〈0.05).The total effective rate was 97.06% in observing group and 82.35% in control group,and there was significant difference in them(P〈0.05).The cadiovascular incident rate was 2.94% in observing group and 17.65% in control group,and there was significant difference in them(P〈0.05).Conclusion:The effect of nadroparin calcium injection combined with simvastatin in treating patients with unstable angina pectoris is superior to that of clopidogrel combined with rosuvastatin,so they are worth being used widly.
出处 《河北医学》 CAS 2010年第4期437-440,共4页 Hebei Medicine
关键词 氯吡格雷片 瑞舒伐他汀 不稳定型心绞痛 Clopidogrel Rosuvastatin Unstable angina pectoris
  • 相关文献

参考文献5

二级参考文献6

共引文献3565

同被引文献72

  • 1陈铁虎,黄宇清.辛伐他汀与氯吡格雷联合治疗不稳定型心绞痛的临床观察[J].基层医学论坛,2009,13(1):36-37. 被引量:6
  • 2姚伟丰,刘云飞,高明喜.瑞舒伐他汀治疗不稳定型心绞痛对血脂、高敏C反应蛋白、同型半胱氨酸和肌钙蛋白的影响[J].中国生化药物杂志,2014,34(1):97-99. 被引量:11
  • 3Huang D, Yang CZ, Yao L, et al. Activation and overexpression of PARP-1 in circulating mononuclear cells promote TNF-alpha and IL-6 expression in patients with unstable angina[J]. Arch Med Res,2008, 39(8) :775-784.
  • 4Vale N, Nordmann A J, Schwartz GG, et al. Statins for acute coronary syndrome [ J ]. Cochrane Database Syst Rev,2011 : CD006870.
  • 5Amane HS, Burte NP. A comparative study of dalteparin and unfractionated heparin in patients with unstable angina pectoris [ J ]. Indian J Pharmacol,2011,43 (6) :703-706.
  • 6Djordjevic VB, Cosic V, Stojanovic I, et al. Lipoproteiu(a) is the best single marker in assessing unstable angina pectoris [ J ]. Cardiol Res Pract ,2011 : 175-363.
  • 7Fonseca FA, Izar MC. Rosuvastatin for cardiovascular prevention : too many uncertainties[J]. Prescrire Int,2009,18 (102) : 176.
  • 8宋少鹏.瑞舒伐他汀对不稳定型心绞痛患者血清细胞因子和心肌缺血的影响[J].临床合理用药杂志,2010,3(20):189-191.
  • 9魏静霞,杨涛.瑞舒伐他汀对不稳定型心绞痛患者疗效及血清IL-6和hs-CRP的影响[J].中山大学学报(医学科学版),2009,30(35):50-51,.
  • 10王吉耀.内科学[M]{H}北京:人民卫生出版社,2006276-277.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部